OSI-774 (Erlotinib, Tarceva) in Elderly Patients

Summary

The purpose of this research study is to determine if OSI-774 (Tarceva) is effective in the treatment of non-small cell lung cancer and to further study its side effects. The investigators would also like to estimate disease-related symptom improvement rates using a questionnaire.

Timeline

Start

2003-07-02

Primary completion

2007-01-12

Completion

2007-01-12

Drugs

Indications